NEVVI Medicare utilization intelligence
or

← back

Provider profile

KHANDELWAL, PANKAJ MD

Medical Oncology · NPI 1114964756 · ODESSA, TX

1
Groups
67
Codes · 2024
96,842
Disclosed services

KHANDELWAL, PANKAJ is a Medical Oncology in ODESSA, TX, a member of 1 medical group, who billed 67 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

96,842
disclosed services
67
codes billed to Medicare Part B
Prior year · CY2023 94,639 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1756 Injection, iron sucrose, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9267 Injection, paclitaxel, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9041 Injection, bortezomib, 0.1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
J2469 Injection, palonosetron hcl, 25 mcg
J0461 Injection, atropine sulfate, 0.01 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96375 Injection of additional new drug or substance into vein
J0640 Injection, leucovorin calcium, per 50 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J3475 Injection, magnesium sulfate, per 500 mg
J9045 Injection, carboplatin, 50 mg
J9190 Injection, fluorouracil, 500 mg
96415 Administration of chemotherapy into vein, each additional hour
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J3480 Injection, potassium chloride, per 2 meq
J3489 Injection, zoledronic acid, 1 mg
96372 Injection of drug or substance under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
83735 Magnesium level
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96361 Infusion into a vein for hydration, each additional hour
J3490 Unclassified drugs
96417 Administration of additional new drug or substance into vein, 1 hour or less
71250 Ct scan of chest without contrast
74176 Ct scan of abdomen and pelvis without contrast
71260 Ct scan of chest with contrast
83615 Lactate dehydrogenase (enzyme) level
74177 Ct scan of abdomen and pelvis with contrast
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J7030 Infusion, normal saline solution , 1000 cc
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96523 Irrigation of implanted venous access drug delivery device
83540 Iron level
83550 Iron binding capacity
82728 Ferritin (blood protein) level
84153 Psa (prostate specific antigen) measurement, total
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
85055 Reticulated (young) platelet measurement
96374 Injection of drug or substance into vein
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
80048 Blood test, basic group of blood chemicals (calcium, total)
82378 Carcinoembryonic antigen (cea) protein level
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96360 Infusion into a vein for hydration, 31-60 minutes
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99195 Drawing of blood for a medical problem
70491 Ct scan of soft tissue of neck with contrast

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.